U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06813261) titled 'GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women' on Jan. 13.
Brief Summary: The aim of this study is to assess the effectiveness of GLYLO, a dietary supplement, in postmenopausal women aged 45 to 65 who are overweight or obese and have elevated HbA1c levels. Specifically, the study seeks to evaluate whether GLYLO can reduce advanced glycation end products (AGEs) levels, which are harmful compounds formed when sugar attaches to proteins or fats in the body and can contribute to aging and disease. The primary outcome of the study is to determine if GLYLO reduces AGEs, enhances metabolic and hormonal health, ...